Efficacy and safety of hypoxia inducible factor-prolyl hydroxylase inhibitors in the treatment of renal anemia in patients undergoing hemodialysis

SHI Ya-nan; HU Zhi-juan; ZHAO Peng; WANG Li-jun; DONG Chun-xia; LIU Jing-yao; NIU Kai; LIU Bing

doi:10.19538/j.nk2020110110

Home>Articles>Efficacy and safety of hypoxia inducible factor-prolyl hydroxylase inhibitors in the treatment of renal anemia in patients undergoing hemodialysis

DOI: 10.19538/j.nk2020110110

Efficacy and safety of hypoxia inducible factor-prolyl hydroxylase inhibitors in the treatment of renal anemia in patients undergoing hemodialysis

SHI Ya-nan

HU Zhi-juan

ZHAO Peng

WANG Li-jun

DONG Chun-xia

LIU Jing-yao

NIU Kai

LIU Bing

Machine-generated Keywords：

Publication Date：2020-11-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 920-925 )

Chinese Journal of Practical Internal Medicine

PKUISTIC

ISSN：1005-2194

Year, Vol.(Issue)：2020,40(11)